# Evommune, Inc.: filings

EVMN · NYSE · CIK 2044725 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/evmn.md) · [Financials](/companies/evmn/financials.md) · [Filings](/companies/evmn/filings.md) · [Insiders](/companies/evmn/insiders.md)

## Reports and events: 27 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 50, 3 15, 8-K 15, 144 6, 424B3 6, D 4, SCHEDULE 13G 4, UPLOAD 4, 10-Q 3, DRS/A 3, DRSLTR 3, FWP 2, S-1 2, S-8 2, SCHEDULE 13D 2, SCHEDULE 13D/A 2, 10-K 1, 424B4 1, 8-A12B 1, ARS 1, CERT 1, CORRESP 1, DEF 14A 1, DEFA14A 1, DRS 1, EFFECT 1, S-1/A 1, SCHEDULE 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-01 | 12:01 ET | [8-K](/filings/0001193125-26-409865.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-409865 |
| 2026-09-23 | 20:05 ET | [8-K](/filings/0001193125-26-399378.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-399378 |
| 2026-09-15 | 12:30 ET | [8-K](/filings/0001193125-26-391390.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-391390 |
| 2026-09-09 | 22:05 ET | [8-K](/filings/0001193125-26-385430.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-385430 |
| 2026-08-06 | 20:09 ET | [10-Q](/filings/0001193125-26-337984.md) | Quarterly report, period 2026-06-30 | 0001193125-26-337984 |
| 2026-08-06 | 20:06 ET | [8-K](/filings/0001193125-26-337964.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-337964 |
| 2026-07-30 | 12:01 ET | [8-K](/filings/0001193125-26-324972.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-324972 |
| 2026-06-29 | 12:32 ET | [8-K](/filings/0001193125-26-286918.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-286918 |
| 2026-06-02 | 20:07 ET | [8-K](/filings/0001193125-26-253482.md) | 5.07 Shareholder vote results | 0001193125-26-253482 |
| 2026-05-07 | 20:16 ET | [10-Q](/filings/0001193125-26-211963.md) | Quarterly report, period 2026-03-31 | 0001193125-26-211963 |
| 2026-05-07 | 20:13 ET | [8-K](/filings/0001193125-26-211934.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001193125-26-211934 |
| 2026-04-21 | 20:05 ET | [DEF 14A](/filings/0001193125-26-166747.md) | Proxy statement, period 2026-04-21 | 0001193125-26-166747 |
| 2026-04-17 | 20:05 ET | [S-1](/filings/0001193125-26-161516.md) | Registration statement | 0001193125-26-161516 |
| 2026-04-13 | 20:09 ET | [8-K](/filings/0001193125-26-152864.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-152864 |
| 2026-03-05 | 21:07 ET | [10-K](/filings/0001193125-26-093932.md) | Annual report, period 2025-12-31 | 0001193125-26-093932 |
| 2026-03-05 | 21:05 ET | [8-K](/filings/0001193125-26-093920.md) | 2.02 Results of operations | 0001193125-26-093920 |
| 2026-02-19 | 21:30 ET | [SCHEDULE 13D/A](/filings/0001193125-26-059504.md) | Ownership report, active investor, amended | 0001193125-26-059504 |
| 2026-02-17 | 00:28 ET | [SCHEDULE 13D/A](/filings/0001346824-26-000063.md) | Ownership report, active investor, amended | 0001346824-26-000063 |
| 2026-02-13 | 13:00 ET | [8-K](/filings/0001193125-26-049888.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-049888 |
| 2026-02-10 | 13:28 ET | [8-K](/filings/0001193125-26-043771.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-043771 |
| 2025-12-11 | 21:15 ET | [10-Q](/filings/0001193125-25-315972.md) | Quarterly report, period 2025-09-30 | 0001193125-25-315972 |
| 2025-12-11 | 21:06 ET | [8-K](/filings/0001193125-25-315918.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-315918 |
| 2025-11-17 | 21:44 ET | [SCHEDULE 13D](/filings/0001346824-25-000063.md) | Ownership report, active investor | 0001346824-25-000063 |
| 2025-11-14 | 21:30 ET | [SCHEDULE 13D](/filings/0001193125-25-283141.md) | Ownership report, active investor | 0001193125-25-283141 |
| 2025-11-07 | 21:01 ET | [8-K](/filings/0001193125-25-272282.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-25-272282 |
| 2025-10-17 | 20:06 ET | [S-1/A](/filings/0001193125-25-242492.md) | Registration statement, amended | 0001193125-25-242492 |
| 2025-10-09 | 18:18 ET | [S-1](/filings/0001193125-25-235673.md) | Registration statement | 0001193125-25-235673 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.